{"DataElement":{"publicId":"2971728","version":"1","preferredName":"Colorectal Tumor Clinical T Stage","preferredDefinition":"the extent of the primary colorectal tumor determined prior to treatment based on evidence obtained from clinical assessment parameters (physical examination, imaging, endoscopy, biopsy, surgical exploration, etc.).","longName":"COLREC_TUM_V7_C_T_ST","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2189081","version":"1","preferredName":"Colorectal Tumor Clinical T Stage","preferredDefinition":"Information related to the clinical T stage of a colorectal tumor.","longName":"COLORECT_TUMOR_C_T","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206583","version":"1","preferredName":"Colorectal Neoplasm","preferredDefinition":"(ko-lo-REK-tul) Having to do with the colon or the rectum.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C13363:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colorectal","conceptCode":"C13363","definition":"Relating to the colon and rectum, or to the entire large bowel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FAFA-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207100","version":"1","preferredName":"Clinical T Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C25398:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-183F-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5DFF7A4-0368-4DFF-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-07","modifiedBy":"TAYLORT","dateModified":"2019-08-28","changeDescription":"8-28-19 ownership transfer approved by CTEP/B.Campbell; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2971716","version":"1","preferredName":"American Joint Committee on Cancer V7 Colorectal Tumor T Stage","preferredDefinition":"the T (tumor) stage for a colorectal tumor as defined by the AJCC Staging Manual, 7th Ed.","longName":"AJCCV7_CREC_TUM_T_ST","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T4b","valueDescription":"Tumor directly invades or is adherent to other organs or structures","ValueMeaning":{"publicId":"2971717","version":"1","preferredName":"Tumor directly invades or is adherent to other organs or structures","longName":"2971717","preferredDefinition":"Tumor directly invades or is adherent to other organs or structures. Note: Direct invasion in T4 includes invasion of other organs or other segments of the colorectum as a result of direct extension through the serosa, as confirmed on microscopic examination (for example, invasion of the sigmoid colon by a carcinoma of the cecum) or, for cancers in a retro-peritoneal or subperitoneal location, direct invasion of other organs or structures by virtue of extension beyond the muscularis propria (i.e., respectively, a tumor on the posterior wall of the descending colon invading the left kidney or lateral abdominal wall; or a mid or distal rectal cancer with invasion of prostate, seminal vesicles, cervix or vagina)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B52EFA1-BF1B-1294-E040-BB89AD4332F7","latestVersionIndicator":"Yes","beginDate":"2009-12-22","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-12-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7B52EFA1-BF34-1294-E040-BB89AD4332F7","beginDate":"2009-12-22","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-12-22","modifiedBy":"ONEDATA","dateModified":"2009-12-22","deletedIndicator":"No"},{"value":"T4a","valueDescription":"Tumor penetrates to the surface of the visceral peritoneum","ValueMeaning":{"publicId":"2971718","version":"1","preferredName":"Tumor penetrates to the surface of the visceral peritoneum","longName":"2971718","preferredDefinition":"Tumor penetrates to the surface of the visceral peritoneum. Tumor that is adherent to other organs or structures, grossly, is classified cT4b. However, if no tumor is present in the adhesion, microscopically, the classification should be pT1-4a depending on the anatomical depth of wall invasion. The V and L classifications should be used to identify the presence or absence of vascular or lymphatic invasion whereas the PN site-specific factor should be used for perineural invasion","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B52EFA1-BF3E-1294-E040-BB89AD4332F7","latestVersionIndicator":"Yes","beginDate":"2009-12-22","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-12-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7B52EFA1-BF57-1294-E040-BB89AD4332F7","beginDate":"2009-12-22","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-12-22","modifiedBy":"ONEDATA","dateModified":"2009-12-22","deletedIndicator":"No"},{"value":"T3","valueDescription":"Tumor invades through the muscularis propria into pericolorectal tissues","ValueMeaning":{"publicId":"2971719","version":"1","preferredName":"Tumor invades through the muscularis propria into pericolorectal tissues","longName":"2971719","preferredDefinition":"Tumor invades through the muscularis propria into pericolorectal tissues","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B52EFA1-BF61-1294-E040-BB89AD4332F7","latestVersionIndicator":"Yes","beginDate":"2009-12-22","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-12-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7B52EFA1-BF7A-1294-E040-BB89AD4332F7","beginDate":"2009-12-22","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-12-22","modifiedBy":"ONEDATA","dateModified":"2009-12-22","deletedIndicator":"No"},{"value":"T2","valueDescription":"TUMOR INVADES MUSCULARIS PROPRIA","ValueMeaning":{"publicId":"2560336","version":"1","preferredName":"TUMOR INVADES MUSCULARIS PROPRIA","longName":"2560336","preferredDefinition":"TUMOR INVADES MUSCULARIS PROPRIA","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8BD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7B52EFA1-BF84-1294-E040-BB89AD4332F7","beginDate":"2009-12-22","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-12-22","modifiedBy":"ONEDATA","dateModified":"2009-12-22","deletedIndicator":"No"},{"value":"T1","valueDescription":"TUMOR INVADES SUBMUCOSA","ValueMeaning":{"publicId":"2560342","version":"1","preferredName":"TUMOR INVADES SUBMUCOSA","longName":"2560342","preferredDefinition":"TUMOR INVADES SUBMUCOSA","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8C3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7B52EFA1-BF8E-1294-E040-BB89AD4332F7","beginDate":"2009-12-22","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-12-22","modifiedBy":"ONEDATA","dateModified":"2009-12-22","deletedIndicator":"No"},{"value":"Tis","valueDescription":"Carcinoma in situ: intraepithelial or invasion of lamina propria","ValueMeaning":{"publicId":"2971720","version":"1","preferredName":"Carcinoma in situ: intraepithelial or invasion of lamina propria","longName":"2971720","preferredDefinition":"Carcinoma in situ: intraepithelial or invasion of lamina propria. Note: Tis includes cancer cells confined within the glandular basement membrane (intraepithelial) or mucosal lamina propria (intramucosal) with no extension through the muscularis mucosae into the submucosa","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B52EFA1-BF98-1294-E040-BB89AD4332F7","latestVersionIndicator":"Yes","beginDate":"2009-12-22","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-12-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7B52EFA1-BFB1-1294-E040-BB89AD4332F7","beginDate":"2009-12-22","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-12-22","modifiedBy":"ONEDATA","dateModified":"2009-12-22","deletedIndicator":"No"},{"value":"T0","valueDescription":"No evidence of primary tumor","ValueMeaning":{"publicId":"2559524","version":"1","preferredName":"No evidence of primary tumor","longName":"2559524","preferredDefinition":"Lung cancer without any evidence of a primary tumor. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Cancer pT0 TNM Finding v6 and v7","conceptCode":"C60966","definition":"Lung cancer without any evidence of a primary tumor. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B591-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7B52EFA1-BFBB-1294-E040-BB89AD4332F7","beginDate":"2009-12-22","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-12-22","modifiedBy":"ONEDATA","dateModified":"2009-12-22","deletedIndicator":"No"},{"value":"TX","valueDescription":"PRIMARY TUMOR CANNOT BE ASSESSED","ValueMeaning":{"publicId":"2559890","version":"1","preferredName":"PRIMARY TUMOR CANNOT BE ASSESSED","longName":"2559890","preferredDefinition":"PRIMARY TUMOR CANNOT BE ASSESSED","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B6FF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7B52EFA1-BFC5-1294-E040-BB89AD4332F7","beginDate":"2009-12-22","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-12-22","modifiedBy":"ONEDATA","dateModified":"2009-12-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2971712","version":"1","preferredName":"American Joint Committee on Cancer Stage","preferredDefinition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C39315:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B52EFA1-BE7C-1294-E040-BB89AD4332F7","latestVersionIndicator":"Yes","beginDate":"2009-12-22","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-12-22","modifiedBy":"ONEDATA","dateModified":"2009-12-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7B52EFA1-BF08-1294-E040-BB89AD4332F7","latestVersionIndicator":"Yes","beginDate":"2009-12-22","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-12-22","modifiedBy":"REEVESD","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811871","version":"1","longName":"Colorectal","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"}]}],"AlternateNames":[{"name":"Alliance","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"Clinical T Stage","type":"Preferred Question Text","description":"Clinical T Stage","url":null,"context":"CTEP"},{"name":"Source","type":"DATA_ELEMENT_SOURCE","description":"AJCC Cancer Staging Manual, 7th Edition","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"T stage","url":null,"context":"Alliance"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"7B53A0EC-6623-D5B5-E040-BB89AD430427","latestVersionIndicator":"Yes","beginDate":"2009-12-22","endDate":null,"createdBy":"SHIDED","dateCreated":"2009-12-22","modifiedBy":"MORENOC","dateModified":"2017-05-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}